- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/05 - Dipeptides
Patent holdings for IPC class A61K 38/05
Total number of patents in this class: 1815
10-year publication summary
|
194
|
162
|
193
|
150
|
169
|
137
|
129
|
117
|
85
|
60
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| SeaGen Inc | 533 |
24 |
| Novmetapharma Co., Ltd. | 82 |
21 |
| Genentech, Inc. | 4099 |
15 |
| Biohaven Therapeutics Ltd. | 121 |
15 |
| The Johns Hopkins University | 5875 |
14 |
| Albireo AB | 176 |
14 |
| Ramot at Tel-Aviv University Ltd. | 1542 |
14 |
| The Regents of the University of California | 20720 |
13 |
| Abbvie Inc. | 1836 |
13 |
| Dana-Farber Cancer Institute, Inc. | 2662 |
13 |
| Oncopeptides Innovation AB | 29 |
13 |
| Azurity Pharmaceuticals, Inc. | 257 |
11 |
| Duke University | 3184 |
10 |
| L.e.a.f. Holdings Group LLC | 124 |
10 |
| Axcella (assignment for The Benefit of Creditors), LLC | 38 |
10 |
| Société des Produits Nestlé S.A. | 10107 |
9 |
| The General Hospital Corporation | 4858 |
9 |
| Ajinomoto Co., Inc. | 2279 |
9 |
| Zymeworks Inc. | 253 |
9 |
| Bristol-myers Squibb Company | 4729 |
8 |
| Other owners | 1561 |